LAVA Therapeutics N.V. offers Gammabody platform, a portfolio of novel bispecific antibodies that engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. The company's lead clinical-stage candidates are LAVA-051, in Phase 1/2a clinical trials for blood cancers (chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia), and LAVA-1207, in Phase 1/2a clinical trials for metastatic castration-resistant prostate cancer. LAVA Therapeutics was incorporated in 2016 and is headquartered in Utrecht, the Netherlands.
What is Lava Therapeutics Nv's quote symbol?
What is the 52 week high and low for Lava Therapeutics Nv (NASDAQ: LVTX)?
How much is Lava Therapeutics Nv stock worth today?
How much is Lava Therapeutics Nv's stock price per share?
What is Lava Therapeutics Nv's Market Cap?